Articles from BayMark Health Services

BayMark Health Services (“BayMark” or the “Company”), a trusted leader in substance use disorder treatment and recovery services throughout North America, today announced it has successfully finalized a strategic transaction with its existing lenders (the “Transaction”). The Transaction has unanimous support across its capital structure, materially strengthens the Company’s balance sheet, and provides the Company with growth capital. This strengthened financial foundation complements the Company’s robust operating performance and provides a clear path forward for long-term stability and sustainable growth. As a result of the Transaction, BayMark is now significantly better positioned to continue providing its best-in-class substance use disorder treatment to over 70,000 patients every day.

LEWISVILLE, Texas, Dec. 17, 2024 (GLOBE NEWSWIRE) -- BayMark Health Services, a trusted leader in substance use disorder treatment and recovery services, is pleased to announce the appointment of Dr. Sergio Huerta and Dr. Peter B. Kassis as Chief Medical Officers for the Opioid Treatment Program (OTP) Division. These strategic appointments reflect the organization's commitment to advancing substance use disorder treatment excellence and its dedication to improving patient outcomes.

LEWISVILLE, Texas, June 24, 2024 (GLOBE NEWSWIRE) -- BayMark Health Services announces that, after a long and successful career in the behavioral health and addiction field, David K. White, PhD, is stepping down from his role as CEO.

BayMark's Study Demonstrates the Path to More Successful Opioid Use Disorder Treatment